These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20979905)

  • 1. [Expression of p53 and flow cytometric analysis of DNA index and S-phase fraction in pterygium].
    Sang AM; Lu H
    Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(27):1890-2. PubMed ID: 20979905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An association between BPDE-like DNA adduct levels and P53 gene mutation in pterygium.
    Lai TJ; Tsai YY; Cheng YW; Chiang CC; Lee H; Chou MC; Chang JH
    Mol Vis; 2006 Dec; 12():1687-91. PubMed ID: 17213797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium.
    Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Chang KC
    Mol Vis; 2005 Jan; 11():50-5. PubMed ID: 15682042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine.
    Perra MT; Maxia C; Corbu A; Minerba L; Demurtas P; Colombari R; Murtas D; Bravo S; Piras F; Sirigu P
    Mol Vis; 2006 Sep; 12():1136-42. PubMed ID: 17093398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity and p53 expression in Pterygium.
    Reisman D; McFadden JW; Lu G
    Cancer Lett; 2004 Mar; 206(1):77-83. PubMed ID: 15019163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of p53 tumor suppressor gene in pterygia.
    Weinstein O; Rosenthal G; Zirkin H; Monos T; Lifshitz T; Argov S
    Eye (Lond); 2002 Sep; 16(5):619-21. PubMed ID: 12194078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation.
    Schneider BG; John-Aryankalayil M; Rowsey JJ; Dushku N; Reid TW
    Exp Eye Res; 2006 Jan; 82(1):91-8. PubMed ID: 16005868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative DNA damage in pterygium.
    Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Lin CL; Chang KC
    Mol Vis; 2005 Jan; 11():71-5. PubMed ID: 15692461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b.
    Chen PL; Cheng YW; Chiang CC; Tseng SH; Chau PS; Tsai YY
    Mol Vis; 2006 Nov; 12():1411-6. PubMed ID: 17149367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
    Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
    Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and significance of p53 protein and Ki-67 protein in pterygium.
    Ljubojević V; Gajanin R; Amidzić L; Vujković Z
    Vojnosanit Pregl; 2016 Jan; 73(1):16-20. PubMed ID: 26964379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
    Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
    J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric DNA analysis, and immunohistochemical p53, PCNA and histopathologic study in primary achalasia: preliminary results.
    Bektas A; Yasa MH; Kuzu I; Dogan I; Unal S; Ormeci N
    Hepatogastroenterology; 2001; 48(38):408-12. PubMed ID: 11379319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry measurements of DNA content in primary and recurrent pterygia.
    Tan DT; Liu YP; Sun L
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1684-6. PubMed ID: 10845586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
    Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometry-pathology combined study of breast cancer].
    Yu ZY; Yu JM; Wu TH; Zhuo PY; Wang SF; Li M; Zhang X; Lü BY; Liu YB
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):420-2. PubMed ID: 16188128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of p53 protein overexpression and DNA ploidy analysis in colon cancer.
    Attallah AM; Elhak NG; Nasif WA; Tabll A; Ezzat F
    Hepatogastroenterology; 1997; 44(18):1595-601. PubMed ID: 9427029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.